GPT-Rosalind (OpenAI) vs Codex (OpenAI)

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Codex (OpenAI)

A
8.3/10

OpenAI's cloud-based coding agent -- runs parallel tasks, proposes PRs, and lives inside ChatGPT

Powered by GPT-5.3-Codex / GPT-5.4

CategoryGPT-Rosalind (OpenAI)Codex (OpenAI)
Ease of Use3.08.0
Output Quality9.08.0
Value7.08.0
Features8.09.0
Overall6.88.3

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Codex (OpenAI)
Free TierNoYes
Starting PriceInvite only$0

Benchmark Head-to-Head

GPT-5.3-Codex benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks

BenchmarkScore
SWE-bench72%
HumanEval95%

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

  • Higher output quality (9 vs 8)

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Codex (OpenAI) if...

  • Easier to use (8 vs 3)
  • Better value for money (8/10)
  • More features (9 vs 8)
  • Has a free tier

Developers already paying for ChatGPT Plus who want a coding agent at no extra cost. Especially good for parallel task execution -- assign multiple bug fixes or feature branches and let Codex work them simultaneously.

Visit Codex (OpenAI)

Our Verdict

Codex (OpenAI) is the clear winner here with 8.3/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Codex (OpenAI) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.